| Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. |
22711227
|
Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC |
Head Neck |
2013 |
PLCO |
| Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. |
22736219
|
Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B |
Cancer |
2013 |
PLCO |
| Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial. |
23262924
|
Partridge EE, Greenlee RT, Riley TL, Commins J, Ragard L, Xu JL, Buys SS, Prorok PC, Fouad MN |
Obstet Gynecol |
2013 |
PLCO |
| A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. |
23295781
|
Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L |
Pancreas |
2013 |
PLCO |
| Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. |
22893105
|
Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H |
Cancer |
2013 |
PLCO |
| Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. |
23065684
|
Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD |
Int. J. Cancer |
2013 |
PLCO |
| An aggregated analysis of hormonal factors and endometrial cancer risk by parity. |
23280123
|
Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV |
Cancer |
2013 |
PLCO |
| Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. |
23112111
|
Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutr… |
Cancer Causes Control |
2013 |
PLCO |
| Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. |
23171878
|
Chaturvedi AK, Moore SC, Hildesheim A |
Am. J. Epidemiol. |
2013 |
PLCO |
| Individual variations in serum melatonin levels through time: implications for epidemiologic studies. |
24376664
|
Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW |
PLoS ONE |
2013 |
PLCO |
| Telomere length and risk of glioma. |
24231251
|
Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA |
Cancer Epidemiol |
2013 |
PLCO |
| The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. |
24115361
|
Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK |
J. Natl. Cancer Inst. |
2013 |
PLCO |
| Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. |
23907431
|
Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J |
Br. J. Cancer |
2013 |
PLCO |
| Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. |
24089460
|
Mir MC, Stephenson AJ, Grubb RL, Black A, Kibel AS, Izmirlian G |
Cancer Epidemiol. Biomarkers Prev. |
2013 |
PLCO |
| Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial. |
23993734
|
Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC |
Lung Cancer |
2013 |
PLCO |
| Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. |
23624999
|
Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL, Hofmann JN, Chow WH, Purdue MP |
Am. J. Epidemiol. |
2013 |
PLCO |
| Association of obesity with cardiovascular disease mortality in the PLCO trial. |
23632233
|
Jiang J, Ahn J, Huang WY, Hayes RB |
Prev Med |
2013 |
PLCO |
| Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. |
23559420
|
Barocas DA, Grubb R, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED |
Cancer |
2013 |
PLCO |
| Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. |
23248253
|
Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL, Berg CD, Urban N, McIntosh MW |
J. Clin. Oncol. |
2013 |
PLCO |
| Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. |
23935463
|
Pfeiffer RM, Park Y, Kreimer AR, Lacey JV, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P |
PLoS Med. |
2013 |
PLCO |
